Novo Nordisk Pulls Plug on Cell Therapy in $1.3B Restructuring Push
The pharma giant will close its cell therapy unit, cutting 250 jobs and ending work on Type 1 diabetes and Parkinson's programs, as new CEO shifts focus to obestiy, diabetes, and liver disease treatments.
Bio-Rad and Gencurix Expand European Access to Precision Cancer Testing
Exclusive distribution deal will bring Droplex digital PCR diagnostic kits to more laboratories across Europe, supporting biomarker-driven treatment decisions in major cancers.